Quintiles, the world’s leading biopharmaceutical services company, and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced a global alliance that brings innovative models to physician detailing to help biotech and pharmaceutical companies increase productivity, overcome complexity and more efficiently demonstrate value for their therapies.

Through a co-promotion agreement covering Europe and the United States,Quintiles and Kadrige will enable biotech and pharma customers to reduce one of their largest fixed costs by transitioning from a traditional healthcare visit model to a “hybrid” model that blends face-to-face physician discussions with live, remote e-detailing calls via the telephone and internet. The co-promotion agreement also enables Quintiles and Kadrige to develop Web-Call centers, which allow medical sales representatives to train or call healthcare professionals on a full-time basis.

This alliance is the first of its kind in the industry. Kadrige and Quintiles’ joint offering provides the full continuum of services and solutions required to evolve smoothly from an aging promotional model to a new one, based on the smart mix of multiple channels of communication that will bring to the biotech or pharma company, cost reductions, sales impact increase and a much larger flexibility to react to market evolutions.

“With Kadrige, we can revolutionize the lifecycle implementation of a brand by customizing physician detailing in accordance with its lifecycle need,” said Michael Ackermann, Senior Vice President of Commercialization for Quintiles. “We are committed to helping our customers succeed in the New Health, and these innovative hybrid call center and multichannel models are the transformative solutions our customers require.”

“While many companies are piloting a hybrid approach, our agreement with Quintiles provides a real-world solution that saves customers time and money by delivering the right message at the right time to the right target through the right channel,” Kadrige Founder and Chairman Olivier Cadou said. “This agreement expands our presence in the U.S. and Europe through access to the largest biotech and pharma sales force in the world.”